High SHP2 expression determines the efficacy of PD-1/PD-L1 inhibitors in advanced KRAS mutant non-small cell lung cancer
SHP2高表达决定了PD-1/PD-L1抑制剂在晚期KRAS突变型非小细胞肺癌中的疗效。
期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.14137
Feng, Hui-Bo; Chen, Yu; Xie, Zhi; Jiang, Jie; Zhong, Yu-Min; Guo, Wei-Bang; Yan, Wen-Qing; Lv, Zhi-Yi; Lu, Dan-Xia; Liang, Hong-Ling; Xu, Fang-Ping; Yang, Jin-Ji; Yang, Xue-Ning; Zhou, Qing; Zhang, Dong-Kun; Zhang, Zhou; Chuai, Shao-Kun; Zhang, Heng-Hui; Wu, Yi-Long; Zhang, Xu-Chao
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
RAS
PD-1
